cas 535961-78-5|| where to buy Benzoyl chloride, 2-fluoro-6-methyl- (9CI)

Название продукции:Benzoyl chloride, 2-fluoro-6-methyl- (9CI)

IUPAC Name:2-fluoro-6-methylbenzoyl chloride

Упаковочная единица	Доступно для заказа	Цена ($)
CM329672-1g	1-2 Weeks	ǆɐ
CM329672-5g	3-4 Weeks	ſɐǆ
CM329672-25g	4-5 Weeks	Ǡǲǲ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 535961-78-5 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:535961-78-5; Молекулярная формула:C8H6ClFO; Точка плавления:-; Smiles-код:O=C(Cl)C1=C(C)C=CC=C1F; Плотность:

: Номер в каталоге:CM329672; Молекулярная масса:172.58; Точка кипения:; Номер Mdl:; Хранение:

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: Zegocractin; CalciMedica announces positive topline data from phase 2b CARPO trial of Auxora™ in Acute Pancreatitis (AP). The trial met primary objective with statistically significant dose response. Calcium release–activated calcium (CRAC) channels are involved in activating T cells, and responsible for regulating calcium-dependent inflammatory pathways or tissue cell injury pathways. AP is a potentially life-threatening inflammatory disease of the pancreas featured by aberrant signaling of calcium.
CalciMedica’s Auxora is a potent and selective intravenous formulated CRAC channel inhibitor containing the active ingredient Zegocractin. It is being developed for the treatment of acute inflammatory and immunologic illnesses, including severe AP, AIPT, AKI, and severe acute respiratory diseases including AHRF, and ARDS.